News for Healthier Living

Multiple Sclerosis Drug Reshapes the Immune System

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that depletes B cells--the immune cells that drive MS progression. Exactly how ocrelizumab does this, however, remains unclear. ...

July 1, 2025


July 3 2025

July 2 2025

July 1 2025

June 30 2025

June 29 2025

June 28 2025

June 27 2025

June 26 2025

June 25 2025

June 24 2025

June 23 2025

June 22 2025

June 21 2025

June 20 2025